Article info

PDF

Original research article
Characterisation of anifrolumab, a fully human anti-interferon receptor antagonist antibody for the treatment of systemic lupus erythematosus

Authors

  1. Correspondence to Dr Gary P Sims; simsg{at}medimmune.com
View Full Text

Citation

Riggs JM, Hanna RN, Rajan B, et al
Characterisation of anifrolumab, a fully human anti-interferon receptor antagonist antibody for the treatment of systemic lupus erythematosus

Publication history

  • Received January 24, 2018
  • Revision received March 2, 2018
  • Accepted March 8, 2018
  • First published April 5, 2018.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.